REPROCELL and VIROCLINICS-DDL Launch New Collaboration in Clinical Research
Processing laboratories are vital for supporting virology clinical trials given the perishable nature of the samples. It is essential to work with partners who can guarantee sample integrity.
VIROCLINICS-DDL is a leading virology contract research organization, serving the biopharmaceutical community with a broad range of preclinical, clinical diagnostic, assay development and clinical trial logistics services. Operating at a global level, VIROCLINICS-DDL is the preferred virology testing laboratory for several of the top-10 biopharmaceutical companies. VIROCLINICS-DDL’s extensive experience with clinical and preclinical studies for viruses, including its specialty in respiratory viruses, puts the company at the forefront in supporting the development of vaccines, antibodies and antiviral compounds targeting viral infectious diseases. VIROCLINICS-DDL is based in the Netherlands and employs more than 270 well-trained, dedicated scientists and technical experts.
Manager Marketing & Communication, Viroclinics-DDL
REPROCELL was established in 2003 to accelerate medical research via cutting-edge stem cell and human tissue-based technologies, including the use of novel transfection reagents and RNA-based methods for the generation of induced pluripotent stem cells. REPROCELL has further diversified its portfolio of products and services to include predictive drug discovery services in human fresh tissues, technologies for the manufacture of bioengineered human tissues, industry-leading gene editing technology and one of the largest commercial repositories of ethically sourced human tissue.
More info: www.reprocell.com
Media Contact: Reprocell
Marketing Manager, Reprocell